Skip to main content
High RiskFDAfda-F-0526-2016OTHER

Tong Ren Tang Shenjing Shuairuo Wan Herbal Supplement 240 pills UPC Code: 6 904579 129602 Distributed by: Solstice Medicine Company

Category
Units Affected
12,500
Recall Date
January 7, 2016
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0526-2016.

Madison One Acme, Inc. dba Solstice Medicine is recalling Tong Ren Tang Shenjing Shuairuo Wan because it contains the unapproved dietary ingredient human placenta which may transmit disease.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0526-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Madison One Acme Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0526-2016.

Madison One Acme Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Madison One Acme Inc Recall FAQ

Madison One Acme Inc is the subject of a supplements safety report: Tong Ren Tang Shenjing Shuairuo Wan Herbal Supplement 240 pills UPC Code: 6 904579 129602 Distributed by: Solstice Medicine Company. The notice was published on January 7, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 12,500 units are potentially affected.